The May 13, 2026, filing presents a stark contrast between the company's strategic ambitions and its current financial reality. While management is pushing a narrative of brand evolution and retail optimization, the underlying data reveals a struggle with debt management and eroding margins. Investors are left to weigh the potential of a successful wellness pivot against the immediate risks of a liquidity crisis and regulatory scrutiny.